BIOTRICITY INC (BTCY:OTCMKTS)
$0.0925 -0.003 (-3.1414%)
Analysed BIOTRICITY INC (BTCY:OTCMKTS) News Sources
Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates
12-11-2025
yahoo.com
Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates
13-11-2025
yahoo.com
Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026
14-11-2025
yahoo.com
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run
23-12-2025
yahoo.com
The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health
24-12-2025
yahoo.com
Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th
05-02-2026
yahoo.com
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA
11-02-2026
yahoo.com
Biotricity Inc (BTCY) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ...
12-02-2026
yahoo.com
Q2 Investor Summit Virtual Live Wednesday June 24
23-06-2026
yahoo.com
Biotricity, Inc to Present at the LD Micro Invitational XVI
12-05-2026
yahoo.com
What is the current price of BIOTRICITY INC (BTCY:OTCMKTS)?
The current price of BIOTRICITY INC (BTCY:OTCMKTS) is $0.0925.
BIOTRICITY INC (BTCY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of BIOTRICITY INC (BTCY:OTCMKTS) since the previous trading day is $-0.003.
BIOTRICITY INC (BTCY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of BIOTRICITY INC (BTCY:OTCMKTS) since the previous trading day is -3.1414%.
What is the most recent average sentiment score for BIOTRICITY INC (BTCY:OTCMKTS)?
The most recent average sentiment score for BIOTRICITY INC (BTCY:OTCMKTS) is 68 out of 100.
What is the most recent average sentiment for BIOTRICITY INC (BTCY:OTCMKTS)?
The most recent sentiment for BIOTRICITY INC (BTCY:OTCMKTS) is .
SEC-8K** Filing Available For BIOTRICITY INC (BTCY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.